4 unknown, 2 completed, 2 recruiting. 4 Phase 3, 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Arginine hydrochloride: new trials by email Literature Review of Arginine hydrochloride trials Research Report on Arginine hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis | Phase 1 / Phase 2 | Recruiting | David K Carroll | 60 | 2025-12-19 | 2026-02-12 |
| Arginine Replacement Therapy in COVID-19 Arginine Hydrochloride - COVID-19 | Phase 2 | Recruiting | Emory University | 21 | 2024-01-08 | 2026-04-15 |
| Prevention of Cancer Development and Progression Arginine hydrochloride - Cancer | Phase 3 | Unknown | Zujiang YU | 300 | 2019-05-10 | 2019-05-07 |
| Novel Treatment of Advanced Hepatocellular Carcinoma Anlotinib Hydrochloride Capsules, Arginine hydrochloride, levamisole - HCC | Phase 3 | Unknown | The First Affiliated Hospital of Zhengzhou University | 300 | 2019-04-10 | 2019-05-15 |
| Treatment of Intermediate-stage Hepatocellular Carcinoma Basic drugs therapy of HCC by TACE, Arginine hydrochloride, Trimetazidine hydrochloride - HCC | Phase 3 | Unknown | The First Affiliated Hospital of Zhengzhou University | 300 | 2017-07-18 | 2017-09-15 |
| Treatment of Advanced Hepatocellular Carcinoma Basic drugs therapy of HCC, Arginine hydrochloride, Trimetazidine hydrochloride - HCC | Phase 3 | Unknown | The First Affiliated Hospital of Zhengzhou University | 300 | 2017-07-18 | 2017-09-12 |
| Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers Intranasal octreotide acetate, Subcutaneous octreotide acetate, Growth hormone-releasing hormone - Healthy Volunteer Study | Phase 1 | Completed | Dauntless Pharmaceuticals | 32 | 2017-01-01 | 2017-05-12 |
| Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients Arginine hydrochloride - Anemia, Sickle Cell, Pneumonia | Phase 2 | Completed | UCSF Benioff Children's Hospital Oakland | 30 | 2001-08-01 | 2015-03-25 |
Anemia, Sickle Cell (1) · COVID-19 (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetic Ketoacidosis (1) · Hyperglycemia (1) · Neoplasms (1) · Pneumonia (1)
The First Affiliated Hospital of Zhengzhou University (3) · Dauntless Pharmaceuticals (1) · David K Carroll (1) · Emory University (1) · UCSF Benioff Children's Hospital Oakland (1) · Zujiang YU (1)
United States (4) · China (3)
Claudia R. Morris, MD (1) · Jeffrey Zacher, MD (1) · Zujiang Yu (1) · Zujiang Yu, Pro,Dr (1)